3-(Methylsulfonylamino)phenylboronic acid, 97.0%, 100g

4-Chlorobenzo[c][1,2,5]oxadiazole, 97%, 5g

2-Chloro-5,6,7,8-tetrahydroquinoline, 95.0%, 250mg

Ethyl 4H-Thieno[3,2-b]pyrrole-5-carboxylate, 97.0%, 1g

3-Bromo-4-nitro-1H-pyrazole, 95.0%, 250mg

5-Bromo-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95+%, 5g

ethyl 5-oxo-1-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylate, 98.0%, 100mg

Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 95.0%, 5g

GC capillary column ROTI®Cap-5, 60 m, 0.53 mm, 2.00 µm, 1 Piece(s)

3-(Methylthio)benzyl alcohol, 97.0%, 50mg

tert-Butyl (5-aminopyridin-2-yl)(methyl)carbamate, 95.0%, 5g

Phenol, 4-[(6,7-dimethoxy-4-quinazolinyl)amino]-, 98%, 25mg

2-{[3-cyano-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridin-2-yl]sulfanyl}acetic acid, 97%, 100mg